135 related articles for article (PubMed ID: 1284103)
1. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis.
Wüthrich B; Kägi MK; Joller-Jemelka H
Arch Dermatol Res; 1992; 284(6):339-42. PubMed ID: 1284103
[TBL] [Abstract][Full Text] [Related]
2. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis.
Kägi MK; Joller-Jemelka H; Wüthrich B
Dermatology; 1992; 185(2):88-92. PubMed ID: 1421636
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in childhood.
Halmerbauer G; Frischer T; Koller DY
Allergy; 1997 Jul; 52(7):765-9. PubMed ID: 9265994
[TBL] [Abstract][Full Text] [Related]
4. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis.
Czech W; Krutmann J; Schöpf E; Kapp A
Br J Dermatol; 1992 Apr; 126(4):351-5. PubMed ID: 1571256
[TBL] [Abstract][Full Text] [Related]
5. Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis.
Furue M; Sugiyama H; Tsukamoto K; Ohtake N; Tamaki K
J Dermatol Sci; 1994 Apr; 7(2):89-95. PubMed ID: 8060919
[TBL] [Abstract][Full Text] [Related]
6. Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis.
Furue M; Koga T; Yamashita N
Br J Dermatol; 1999 Jan; 140(1):67-72. PubMed ID: 10215770
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of serologic immune parameters in inflammatory skin diseases.
Gebhardt M; Wenzel HC; Hipler UC; Herrmann D; Wollina U
Allergy; 1997 Nov; 52(11):1087-94. PubMed ID: 9404560
[TBL] [Abstract][Full Text] [Related]
8. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity.
Walker C; Kägi MK; Ingold P; Braun P; Blaser K; Bruijnzeel-Koomen CA; Wüthrich B
Clin Exp Allergy; 1993 Feb; 23(2):145-53. PubMed ID: 8448682
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous CD30+ cells in children with atopic dermatitis.
Cavagni G; Caffarelli C; Facchetti F; Brugnoni D; Notarangelo LD; Tosoni C; Altobelli R
Int Arch Allergy Immunol; 2000 Mar; 121(3):224-8. PubMed ID: 10729781
[TBL] [Abstract][Full Text] [Related]
10. [The role of eosinophilic granulocytes for the pathogenesis of atopic dermatitis /neurodermatitis. Eosinophilic products as markers of disease activity].
Kapp A
Hautarzt; 1993 Jul; 44(7):432-6. PubMed ID: 8365876
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
Stelmach I; Jerzynska J; Kuna P
J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
[TBL] [Abstract][Full Text] [Related]
12. Serum eosinophil cationic protein in patients with atopic dermatitis.
Paganelli R; Fanales-Belasio E; Carmini D; Scala E; Meglio P; Businco L; Aiuti F
Int Arch Allergy Appl Immunol; 1991; 96(2):175-8. PubMed ID: 1769747
[TBL] [Abstract][Full Text] [Related]
13. [The study of immunological markers in patients with "intrinsic" type atopic dermatitis].
Yamashiro M; Okubo Y; Kato Y; Tamaki T; Koga M
Arerugi; 2002 Jul; 51(7):552-8. PubMed ID: 12201168
[TBL] [Abstract][Full Text] [Related]
14. [Peripheral eosinophil counts relates the improvement of the skin lesions of atopic dermatitis patients more sensitive than serum eosinophil cationic protein levels].
Nishimoto M; Numahara T; Nakashima K; Yoshida T
Arerugi; 1998 Jun; 47(6):591-6. PubMed ID: 9721450
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD30 and cyclosporine in severe atopic dermatitis.
Caproni M; Salvatore E; Cardinali C; Brazzini B; Fabbri P
Int Arch Allergy Immunol; 2000 Apr; 121(4):324-8. PubMed ID: 10828723
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of soluble CD23 in patients with asthma or rhinitis monosensitive to Parietaria. Its relation to total serum IgE levels and eosinophil cationic protein during and out of the pollen season.
Di Lorenzo G; Drago A; Pellitteri ME; Candore G; Colombo A; Potestio M; Di Salvo A; Mansueto S; Caruso C
Allergy Asthma Proc; 1999; 20(2):119-25. PubMed ID: 10209690
[TBL] [Abstract][Full Text] [Related]
17. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction.
Ott NL; Gleich GJ; Peterson EA; Fujisawa T; Sur S; Leiferman KM
J Allergy Clin Immunol; 1994 Jul; 94(1):120-8. PubMed ID: 8027490
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil involvement in atopic dermatitis as reflected by elevated serum levels of eosinophil cationic protein.
Tsuda S; Kato K; Miyasato M; Sasai Y
J Dermatol; 1992 Apr; 19(4):208-13. PubMed ID: 1607481
[TBL] [Abstract][Full Text] [Related]
19. Measurement of inflammatory mediators of eosinophils and lymphocytes in blood in acute asthma: serum levels of ECP influence the bronchodilator response.
Di Lorenzo G; Pacor ML; Morici G; Drago A; Esposito-Pellitteri M; Candore G; Lo Bianco C; Caruso C
Int Arch Allergy Immunol; 2002 Apr; 127(4):308-15. PubMed ID: 12021550
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 release from peripheral blood monocytes and soluble interleukin-2 and CD8 receptors in serum from patients with atopic dermatitis.
Thestrup-Pedersen K; Larsen CS; Kristensen M; Zachariae C
Acta Derm Venereol; 1990; 70(5):395-9. PubMed ID: 1980972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
